Moderna to Join Nasdaq-100 Index on October 9
nashnova research
Nasdaq announced that Moderna will replace Warner Bros. Discovery in the Nasdaq-100 on October 9; passive funds tracking the index must buy Moderna and sell Warner Bros. Discovery around that date, creating a clear short-term shift in capital flows.
Who is being swapped?
Nasdaq announced that Moderna will officially join the Nasdaq-100 index on October 9.
It replaces Warner Bros. Discovery, which loses its constituent seat.
The Nasdaq-100 — a benchmark tracking the 100 largest non-financial companies on the Nasdaq exchange — adjusts individual seats outside its regular quarterly rebalance. This means → this is a special single-name replacement, not a broad reshuffle.
Why does this move stock prices?
A large pool of passive funds and ETFs track the Nasdaq-100 and must replicate its composition.
Around the effective date, these funds are forced to buy Moderna and sell Warner Bros. Discovery.
In plain terms = regardless of what any fund manager thinks about either company, the rules compel a buy on one side and a sell on the other — that is what "passive flow" means.
What does it mean for ordinary investors?
Moderna may receive a short-term wave of index-inclusion buying support; Warner Bros. Discovery faces selling pressure.
This means → around October 9, trading volume and volatility in both stocks will likely spike.
But this type of capital flow is a one-off event and does not change either company's fundamentals — the price distortion typically fades within a few trading sessions.
市场有风险，内容仅供研究参考，不构成投资建议。